APR Applied Pharma Research s.a.

πŸ“ Balerna, SwitzerlandπŸ—“ Founded 1990πŸ‘₯ 50 employeesπŸ’° Last funded Apr 2015
APR (part of Relief Therapeutics) is a Swiss-based international biopharmaceutical company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases. APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management. A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases. Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
1990
Founded
Investor geography1 country
Switzerland
2
Frequently asked questions
Who invested in APR Applied Pharma Research s.a.?
APR Applied Pharma Research s.a. has 2 investors on record on gritt.io.
When did APR Applied Pharma Research s.a. last raise funding?
The most recent investment in APR Applied Pharma Research s.a. recorded on gritt.io was in April 2015.
When was APR Applied Pharma Research s.a. founded?
APR Applied Pharma Research s.a. was founded in 1990.
What industry is APR Applied Pharma Research s.a. in?
APR Applied Pharma Research s.a. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is APR Applied Pharma Research s.a. based?
APR Applied Pharma Research s.a. is headquartered in Balerna, Switzerland.